Alan G. Spoon
Alan G. Spoon's purchase track record
Alan G. Spoon has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/2/2022 | FTV | $1.01M | +9.8% | +9.0% | -6.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Ralliant (RAL) receives analyst upgrades and price target changes. Ralliant announced the date for its third‑quarter 2026 earnings release and conference call. RBC Capital kept its sector‑perform rating but lowered the price target to $72, while Seaport Global upgraded the stock to Buy with an $88 target. The mixed analyst actions suggest both caution over higher costs and optimism about growth opportunities. The stock is near its 52‑week high and below the average analyst target of $79.18.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Danaher Expands AI Integration in Scientific Research. Danaher has announced a partnership to integrate AI into scientific research workflows, a move that could enhance its diagnostic and drug discovery capabilities. With Q3 earnings approaching, investors are watching to see if this strategic shift supports the company's recovery narrative. The stock currently trades near its 52-week high, reflecting optimism about these operational improvements.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
MTCH Featured in Small-Cap Outlook and Bullish Commentary. A SeekingAlpha piece calls MTCH a stock worth watching, noting its recent performance and potential upside. Yahoo’s small‑cap roundup includes MTCH as one of the companies with promising prospects, highlighting its growth trajectory. The stock sits within its 52‑week range and shows a neutral RSI, suggesting room for movement. These pieces add fresh attention to the company’s profile.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RBC lowers Fortive price target to $59. RBC Capital cut its price target for Fortive to $59 while maintaining a Sector Perform rating. Recent analysis suggests that while current demand remains stable, earnings growth in the second half of the year is not accelerating. This cautious outlook aligns with the stock trading near its recent support levels, reflecting a market that is waiting for clearer signs of momentum.
Transaction History
| PPLI | ▲ Buy | Option Exercise | 2,263 | $0 | 6/18/2026 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,609 | $0 | 6/15/2026 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 2,076 | $0 | 6/11/2026 | View on chart |
| RAL | ▲ Buy | Grant | 3,225 | $0 | 6/5/2026 | View on chart |
| DHR | ▲ Buy | Grant | 680 | $0 | 5/15/2026 | View on chart |
| DHR | ▲ Buy | Option Exercise | 3,298 | $237K | 5/1/2026 | View on chart |
| DHR | ▼ Sell | Open Market | 1,358 | $237K | 5/1/2026 | View on chart |
| RAL | ▲ Buy | Grant | 3,403 | $0 | 6/30/2025 | View on chart |
| PPLI | ▲ Buy | Grant | 1,257 | $0 | 6/23/2025 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 8,061 | — | 6/18/2025 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 99 | — | 6/18/2025 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,610 | $0 | 6/15/2025 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 2,076 | $0 | 6/11/2025 | View on chart |
| DHR | ▲ Buy | Grant | 577 | $0 | 5/15/2025 | View on chart |
| DHR | ▲ Buy | Option Exercise | 3,928 | $233K | 2/7/2025 | View on chart |
| DHR | ▼ Sell | Open Market | 550 | $114K | 2/7/2025 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,034 | $0 | 6/23/2024 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 6,088 | — | 6/22/2024 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 585 | — | 6/15/2024 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,325 | $0 | 6/15/2024 | View on chart |
| FTV | ▲ Buy | Grant | 2,885 | $0 | 6/3/2024 | View on chart |
| FTV | ▲ Buy | Grant | 2,860 | $218K | 6/3/2024 | View on chart |
| DHR | ▲ Buy | Grant | 390 | $0 | 5/15/2024 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 549 | $0 | 5/14/2024 | View on chart |
| DHR | ▼ Sell | Open Market | 708 | $172K | 5/2/2024 | View on chart |
| DHR | ▲ Buy | Option Exercise | 3,289 | $173K | 5/2/2024 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 800 | — | 6/30/2023 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,347 | $0 | 6/25/2023 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,034 | $0 | 6/23/2023 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 585 | — | 6/15/2023 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 2,953 | — | 6/8/2023 | View on chart |
| FTV | ▲ Buy | Grant | 3,345 | $0 | 6/6/2023 | View on chart |
| FTV | ▲ Buy | Grant | 1,660 | $109K | 6/6/2023 | View on chart |
| DHR | ▲ Buy | Grant | 430 | $0 | 5/15/2023 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 549 | $0 | 5/14/2023 | View on chart |
| DHR | ▲ Buy | Option Exercise | 3,490 | $177K | 10/25/2022 | View on chart |
| DHR | ▼ Sell | Open Market | 500 | $126K | 10/25/2022 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 801 | — | 6/30/2022 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,346 | $0 | 6/25/2022 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 1,225 | — | 6/19/2022 | View on chart |
| MTCH | ▲ Buy | Option Exercise | 586 | — | 6/15/2022 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,788 | $0 | 6/12/2022 | View on chart |
| FTV | ▲ Buy | Grant | 2,285 | $0 | 6/6/2022 | View on chart |
| FTV | ▲ Buy | Grant | 1,905 | $114K | 6/6/2022 | View on chart |
| DHR | ▲ Buy | Grant | 372 | $0 | 5/15/2022 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 548 | $0 | 5/14/2022 | View on chart |
| FTV | ▲ Buy | Open Market | 6,300 | $364K | 5/2/2022 | View on chart |
| FTV | ▲ Buy | Open Market | 11,100 | $650K | 5/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
PPLI Sets Q3 2026 Earnings Date as Sector Faces Volatility
People Incorporated announced it will hold its Q3 2026 earnings conference call on November 3rd. This update arrives while broader casino stocks, including MGM and Wynn, are experiencing record losing streaks, creating a volatile backdrop for the sector. The company's upcoming results will be a key focal point for investors watching how PPLI navigates these industry-wide pressures.
PPLI Sets Q3 2026 Earnings Date as Sector Faces Volatility. People Incorporated announced it will hold its Q3 2026 earnings conference call on November 3rd. This update arrives while broader casino stocks, including MGM and Wynn, are experiencing record losing streaks, creating a volatile backdrop for the sector. The company's upcoming results will be a key focal point for investors watching how PPLI navigates these industry-wide pressures.